170 related articles for article (PubMed ID: 3085596)
21. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
23. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
24. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility to exogenously added interferon-beta protein depends on intracellular interferon-beta mRNA level in human glioma cells.
Osawa H; Mizuno M; Hatano M; Nakahara N; Tsuno T; Kuno T; Endo M; Yoshida J
Cytokine; 2005 Dec; 32(5):240-5. PubMed ID: 16343929
[TBL] [Abstract][Full Text] [Related]
26. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
27. Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model.
Sakamoto K; Hoshino H; Kiuchi Y; Nakano G; Nagamachi Y
Jpn J Exp Med; 1989 Oct; 59(5):173-80. PubMed ID: 2559217
[TBL] [Abstract][Full Text] [Related]
28. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
29. In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.
Hong WS; Saijo N; Sasaki Y; Shinkai T; Eguchi K; Sakurai M; Takahashi H; Nakano H; Nakagawa K; Twentyman PR
Jpn J Cancer Res; 1987 Nov; 78(11):1274-80. PubMed ID: 3121562
[TBL] [Abstract][Full Text] [Related]
30. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r.
Watanabe N; Niitsu Y; Yamauchi N; Umeno H; Sone H; Neda H; Urushizaki I
J Biol Response Mod; 1988 Feb; 7(1):24-31. PubMed ID: 2453618
[TBL] [Abstract][Full Text] [Related]
31. Augmentation of cytotoxic activity of recombinant human tumor necrosis factor (rHu-TNF) by recombinant human interferon-gamma (rHu-IFN-gamma).
Taguchi T; Kimoto Y; Tanji Y; Abe S; Nakano K; Sohmura Y
J Biol Response Mod; 1987 Dec; 6(6):599-609. PubMed ID: 3131488
[TBL] [Abstract][Full Text] [Related]
32. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
[TBL] [Abstract][Full Text] [Related]
33. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
Son MJ; Song HS; Kim MH; Kim JT; Kang CM; Jeon JW; Park SY; Kim YJ; Groves MD; Park K; Kim JH; Nam DH
Int J Oncol; 2006 Jun; 28(6):1385-92. PubMed ID: 16685440
[TBL] [Abstract][Full Text] [Related]
35. Effects of intracarotid and intravenous infusion of human TNF and LT on established intracerebral rat gliomas.
Liu SK; Jakowatz JG; Pollack RB; Ceraldi C; Yamamoto R; Dett C; Lopez F; Camacho C; Carson WE; Sentovich SM
Lymphokine Cytokine Res; 1991 Jun; 10(3):189-94. PubMed ID: 1883913
[TBL] [Abstract][Full Text] [Related]
36. Short- and long-term synergistic effects of human tumor necrosis factor and interferon-gamma on A549 human lung cancer cells maintained in three-dimensional culture.
Beaupain R; Martyré MC
Anticancer Res; 1990; 10(4):1061-6. PubMed ID: 2116752
[TBL] [Abstract][Full Text] [Related]
37. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
Onishi T; Machida T; Masuda F; Iizuka N; Nakauchi K; Furuta N; Shirakawa H
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1571-8. PubMed ID: 2121869
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of pGL1-TNF-alpha therapy in combination with radiation.
Li J; Andres ML; Fodor I; Nelson GA; Gridley DS
Oncol Res; 1998; 10(7):379-87. PubMed ID: 10063972
[TBL] [Abstract][Full Text] [Related]
39. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin.
Sacchi A; Gasparri A; Curnis F; Bellone M; Corti A
Cancer Res; 2004 Oct; 64(19):7150-5. PubMed ID: 15466213
[TBL] [Abstract][Full Text] [Related]
40. Cytostatic and cytolytic effects of human recombinant tumor necrosis factor on human renal cell carcinoma cell lines derived from a single surgical specimen.
Heicappell R; Naito S; Ichinose Y; Creasey AA; Lin LS; Fidler IJ
J Immunol; 1987 Mar; 138(5):1634-40. PubMed ID: 3805727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]